Serviços digitais farmacêuticos em unidades oncológicas hospitalares.

Abstract

Oncological treatment causes the patient to experience adverse reactions that compromise adherence to anticancer treatment, safety and quality of life of the patient. Therefore, pharmacotherapeutic monitoring is important, which can be facilitated through digital health services. Therefore, this research aimed to design a project of digital pharmaceutical services in hospital oncology units. The present study is an integrative literature review, seeking to identify problems and opportunities inherent to the pharmacotherapeutic follow-up performed by the hospital and clinical pharmacist in hospital oncology units. For this, advanced searches were carried out in the databases Periodicals CAPES, LILACS, PubMed, Scielo and Science Direct, using descriptors searched in the database of the Descriptors in Health Sciences (DeCS) platform, they were: pharmacotherapeutic monitoring, cancer, telepharmacy, hospital pharmacy service, hospital oncology service and their respective translations into English. The articles included in the research were published between 2016 and 2021 in Portuguese and English. Then, a survey of Brazilian startups that provide digital health services was carried out. For this, the study “Distrito Healthtech Report Brazil 2020” was used as a research source. Finally, a technical project of digital pharmaceutical services was designed based on the Canvas methodology, through the 3 questions: “What?”, “For whom?” It is like?". The results obtained after the advanced searches were 12,314 publications, of which 17 full-length scientific articles were included in the study. From the searches of startups, 542 were cataloged, separated into 9 categories, but only 3 categories were explored: telemedicine, access to information and management/PEP, totaling 283 startups, of which 6 were included in the study. Through the Canvas methodology, the following answers were obtained: “What?” is a digital health platform that will provide pharmaceutical services; "For whom?" for oncology pharmacists; "How?" through teleconsultations mediated by Artificial Intelligence (AI). Therefore, it was concluded that the use of Information and Communication Technologies (ICT) in the health area benefits countless professionals and patients. Therefore, to propose a digital ecosystem idealizing a platform to offer pharmaceutical services, focusing on oncology pharmacists and cancer patients undergoing treatment; in order to reduce expenses and time of care, increase adherence to pharmacotherapy and provide knowledge sharing.